Earlier scientific reports of CagriSema observed that it served sufferers attain appreciably increased weight loss than semaglutide (Wegovy) did. regardless of whether Lilly's Zepbound/Mounjaro topples Wegovy, It truly is probable that CagriSema could enter the industry at the best time for Novo Nordisk to retain its Total Management from the weigh